Endogastric Solutions Logo
  • Home
  • Patients
    • Take me to Gerdhelp.com
  • Providers
    • TIF 2.0®
      • EsophyX® Device
    • cTIF™
    • Support
      • Training and Education
      • Reimbursement
      • Community Outreach
      • Regulatory Labeling
      • Data & Bibliography
    • Referring Physicians
    • Events
  • About Us
    • Leadership
      • Executive Team
      • Medical Advisory Board
      • Board of Directors
    • Careers
    • Investors
    • News
      • Press Releases
      • Videos
  • Contact
Endogastric Solutions Logo
  • Patients
  • Providers
  • About Us
  • Contact

EndoGastric Solutions Announces 12-Month Registry Data Show Durable Elimination of Troublesome Regurgitation and Heartburn for GERD Patients Who Underwent Transoral Incisionless Fundoplication (TIF®)

Feb 20, 2014

Results show 74% of patients were able to stop taking and remain off proton pump inhibitor medications at 12-month follow up SAN MATEO, Calif. (February 20, 2014)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for Gastroesophageal...

Corporate Statement Regarding Civil Settlement with the U.S. Department of Justice

Feb 19, 2014

SAN MATEO, Calif. (February 19, 2014)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease, announced today that it has reached a civil settlement with the U.S. Department of Justice related to...

EndoGastric Solutions Announces RESPECT Trial Exceeds Enrollment Target

Oct 8, 2013

Randomized, head-to-head study represents most comprehensive effort to date to compare Transoral Incisionless Fundoplication (TIF®) outcomes to sham surgery and PPI therapy in patients with GERD Company also announces 14,000 patients treated with TIF procedure since...

Incisionless Endoscopic Procedure Significantly More Effective at Eliminating Chronic GERD Symptoms than Maximum PPI Dose, New Data Show

May 21, 2013

TEMPO Study Level 1 Data Directly Comparing Transoral Incisionless Fundoplication (TIF) Procedure to PPI Use Presented at DDW® 2013 Redwood City, CA (May 21, 2013)–EndoGastric Solutions® (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal...
« Older Entries
Next Entries »
EndoGastric Solutions logo
  • Patients
  • Providers
  • About Us
  • Contact Us
  • GERDHelp for Patients
  • References
  • Privacy
  • Terms of Use
  • Social Media Policy
  • Corporate Compliance
  • Facebook
  • X
  • Instagram
  • RSS
© 2023 EndoGastric Solutions, Inc. All rights reserved.
EndoGastric, EsophyX, SerosaFuse, TIF, TIF 2.0 and cTIF names and logos, are registered trademarks of EndoGastric Solutions. All other product names and logos are trademarks or registered trademarks of their respective holders.